FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee)

Agenda:
The Air Force will present for review to the Ranch Hand Advisory Committee the following chapters from the ongoing health study: Chapter 18, Endocrine; Chapter 20, Pulmonary; Chapter 11, Neurology; Chapter 13, Gastrointestinal; Chapter 14, Dermatology; Chapter 10, Neoplasia; Chapter 21, Conclusions; and the Executive Summary.

Background material and meeting information will become available no later than one business day before the meeting (Simply select the appropriate committee link).

Procedure:
Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by November 5, 2004. Oral presentations from the public will be scheduled between approximately 10:20 a.m. and 10:55 a.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before November 12, 2004, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets.

FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Leonard Schechtman at least 7 days in advance of the meeting.

Contact Person:
Leonard Schechtman, National Center for Toxicological Research (HFT-10), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–6696, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512560. Please call the Information Line for up-to-date information on this meeting.